Hidden in the Data: The Case of the Risk Your RACT Didn’t Predict

Clinical trial risk management begins prospectively: identify critical-to-quality factors, assess what could go wrong, and establish the indicators and thresholds that will tell us when it does. But what happens when the trial does something we didn’t predict?

In this technology showcase, we'll investigate an emerging risk that was never defined in the RACT. Like any good investigation, the answer isn’t found in a single piece of evidence. Clinical data management sees one signal. Clinical operations sees another. Biostatistics and programming uncover additional clues. Each function is an eyewitness to a different part of the story—and only when those perspectives and data are brought together does the full pattern emerge.

Using an investigation-inspired demonstration, we’ll follow the evidence across integrated clinical and operational data in the elluminate® Clinical Data Intelligence Platform to uncover an unexpected pattern, identify the subjects and sites involved, assess whether the signal represents meaningful trial risk, and determine the appropriate response.

The case illustrates a broader evolution in risk-based quality management: risk detection is a cross-functional property of the trial. Effective oversight requires more than monitoring the risks we anticipated; it requires an environment in which new signals can be recognized, contextualized, communicated, and acted upon as the trial evolves. The question isn’t simply whether your study is monitoring its known risks, but whether your data can tell you when a new risk has arrived, and help you act on it.